Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: Immunai does not list a price
Free plan
Tie
Neither has one
Higher rating
Unlearn.AI
4.0 against 4.2
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
Immunai
Unlearn.AI
Our rating
4.0
4.2Better
Starts at
Not listed
Not listed
Free plan
No
No
Category
Healthcare AI
Healthcare AI
Plans
See pricing
See pricing
Key features
AMICA-OS platform built on single-cell multi-omic immune system data
Target discovery tools for identifying new drug candidates from immune cell behavior
Preclinical evaluation modeling for testing target hypotheses before trials
Clinical trial optimization using immune-response data
One of the industry's largest clinical immunology datasets, built through 30-plus pharma partnerships
Digital twins forecasting participant outcomes
Control arm size reduction of around 33 percent
Scout for literature and regulatory search
Hindsight dataset exploration and SimLab scenario modelling
Real-time trial quality monitoring
Pros
Dataset scale, built through partnerships with Fortune 100 pharma companies, gives its models depth smaller labs can't replicate
Covers the full pipeline from target discovery through clinical trial optimization rather than one narrow step
Named partnerships with AstraZeneca, Boehringer Ingelheim, Pfizer, and Novo Nordisk demonstrate real commercial traction
Fewer control participants is an ethical gain as well as a commercial one
Covers planning, monitoring and analysis rather than one stage
Four-plus months of enrolment time saved on their figures
Cons
No published pricing; every engagement is a custom partnership negotiation
Built exclusively for pharmaceutical R&D, inaccessible to academic labs or individual researchers without a deal
Value depends on data-sharing arrangements with partners, which take time to negotiate and set up
No published pricing
Digital twin methods need regulatory acceptance per trial context
A forecast substituting for an observation is an argument reviewers must accept
Company
Immunai, founded 2018
Unlearn.ai, Inc.
Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.
FAQ
Questions people ask
Is Immunai better than Unlearn.AI?
In our reviews Immunai scores 4.0 and Unlearn.AI scores 4.2. The better pick depends on the job. Immunai: AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners. Unlearn.AI: Digital twins of trial participants that shrink the control arm by about a third.
Unlearn.AI
Immunai
